 | • レポートコード：QAF21808 • 出版社/出版日：QYResearch / 2021年3月31日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、134ページ • 納品方法：Eメール（即日納品） • 産業分類：化学＆材料 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界の低分子量ヘパリン市場について種類別（エノキサパリン、ダルテパリン、チンザパリン、フラキシパリン）、用途別（静脈血栓塞栓症治療、妊娠合併症、心房細動/粗動電気的除細動、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・低分子量ヘパリン市場の概要 ・世界の主要地域別低分子量ヘパリン市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界の低分子量ヘパリン市場規模2016-2021：種類別（エノキサパリン、ダルテパリン、チンザパリン、フラキシパリン） ・世界の低分子量ヘパリン市場予測2012-2027：種類別（エノキサパリン、ダルテパリン、チンザパリン、フラキシパリン） ・世界の低分子量ヘパリン市場規模2016-2021：用途別（静脈血栓塞栓症治療、妊娠合併症、心房細動/粗動電気的除細動、その他） ・世界の低分子量ヘパリン市場予測2012-2027：用途別（静脈血栓塞栓症治療、妊娠合併症、心房細動/粗動電気的除細動、その他） ・低分子量ヘパリンのアメリカ市場規模と予測2016-2021 ・低分子量ヘパリンのヨーロッパ市場規模と予測2016-2021 ・低分子量ヘパリンの中国市場規模と予測2016-2021 ・低分子量ヘパリンの日本市場規模と予測2016-2021 ・低分子量ヘパリンの東南アジア市場規模と予測2016-2021 ・低分子量ヘパリンのインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Aspen、Sanofi-aventis、Pfizer、Opocrin、CSBIO、Dongying Tiandong Pharmaceutical、Changzhou Qianhong Bio-pharma、Techdow、Yantai Dongcheng Pharmaceutical Group） ・低分子量ヘパリンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・低分子量ヘパリンの市場動向・機会・課題 ・調査の結論 |
Low Molecular Weight Heparin (LMWHs) is derived from UFH (Unfractionated heparin) by such processes as chemical degradation, enzymatic depolymerisation and gamma-radiation cleavage.
Natural heparin consists of molecular chains of varying lengths, or molecular weights. Chains of varying molecular weights, from 5000 to over 40,000 Daltons, make up polydisperse pharmaceutical-grade heparin. LMWHs, in contrast, consist of only short chains of polysaccharide. LMWHs are defined as heparin salts having an average molecular weight of less than 8000 Da and for which at least 60% of all chains have a molecular weight less than 8000 Da.
In 2016, in term of volume, the global Low molecular weight heparin market is led by china, capturing about 49.57% of global low molecular weight heparin production. In term of revenue, USA is the second’s largest market with the share of 30.49%.
At present, the major manufacturers of Low Molecular Weight Heparin are Aspen, Sanofi-aventis, Pfizer, Opocrin, CSBIO, Dongying Tiandong Pharmaceutical, Changzhou Qianhong Bio-pharma, Techdow, Yantai Dongcheng Pharmaceutical Group, etc. Aspen, Sanofi-aventis and Pfizer are industry-leading manufacturers of top-quality Low Molecular Weight Heparins.
China is a big low molecular weight heparin production country, especially Heparin API, but it is not strong country. According to our research and analysis, manufacturers from United States and Europe are the major leaders in the international market of low molecular weight heparin. Manufacturers from China are immature in technology. There is large space in the China market, as well as big gap between international brands and local brands on price.
In application, low molecular weight heparin downstream is wide and recently low molecular weight heparin has acquired increasing significance in various fields of treatment of venous thromboembolism, complications of pregnancy, cardioversion of atrial fibrillation/flutter and others.
Globally, the low molecular weight heparin market is mainly driven by growing demand for treatment of venous thromboembolism which accounts for nearly 65.24% of total downstream consumption of low molecular weight heparin in global.
Market Analysis and Insights: Global Low Molecular Weight Heparin Market
The global Low Molecular Weight Heparin market was valued at US$ 338.6 in 2020 and will reach US$ 464.2 million by the end of 2027, growing at a CAGR of 5.4% during 2022-2027.
Global Low Molecular Weight Heparin Scope and Market Size
The global Low Molecular Weight Heparin market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Low Molecular Weight Heparin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Enoxaparin
Dalteparin
Tinzaparin
Fraxiparine
Segment by Application
Treatment of Venous Thromboembolism
Complications of Pregnancy
Cardioversion of Atrial Fibrillation/Flutter
Others
The Low Molecular Weight Heparin market is analysed and market size information is provided by regions (countries). Segment by Application, the Low Molecular Weight Heparin market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Aspen
Sanofi-aventis
Pfizer
Opocrin
CSBIO
Dongying Tiandong Pharmaceutical
Changzhou Qianhong Bio-pharma
Techdow
Yantai Dongcheng Pharmaceutical Group
1 Low Molecular Weight Heparin Market Overview
1.1 Low Molecular Weight Heparin Product Scope
1.2 Low Molecular Weight Heparin Segment by Type
1.2.1 Global Low Molecular Weight Heparin Sales by Type (2016 & 2021 & 2027)
1.2.2 Enoxaparin
1.2.3 Dalteparin
1.2.4 Tinzaparin
1.2.5 Fraxiparine
1.3 Low Molecular Weight Heparin Segment by Application
1.3.1 Global Low Molecular Weight Heparin Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Treatment of Venous Thromboembolism
1.3.3 Complications of Pregnancy
1.3.4 Cardioversion of Atrial Fibrillation/Flutter
1.3.5 Others
1.4 Low Molecular Weight Heparin Market Estimates and Forecasts (2016-2027)
1.4.1 Global Low Molecular Weight Heparin Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Low Molecular Weight Heparin Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Low Molecular Weight Heparin Price Trends (2016-2027)
2 Low Molecular Weight Heparin Estimates and Forecasts by Region
2.1 Global Low Molecular Weight Heparin Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Low Molecular Weight Heparin Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Low Molecular Weight Heparin Sales Market Share by Region (2016-2021)
2.2.2 Global Low Molecular Weight Heparin Revenue Market Share by Region (2016-2021)
2.3 Global Low Molecular Weight Heparin Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Low Molecular Weight Heparin Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Low Molecular Weight Heparin Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Low Molecular Weight Heparin Estimates and Projections (2016-2027)
2.4.2 Europe Low Molecular Weight Heparin Estimates and Projections (2016-2027)
2.4.3 China Low Molecular Weight Heparin Estimates and Projections (2016-2027)
2.4.4 Japan Low Molecular Weight Heparin Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Low Molecular Weight Heparin Estimates and Projections (2016-2027)
2.4.6 India Low Molecular Weight Heparin Estimates and Projections (2016-2027)
3 Global Low Molecular Weight Heparin Competition Landscape by Players
3.1 Global Top Low Molecular Weight Heparin Players by Sales (2016-2021)
3.2 Global Top Low Molecular Weight Heparin Players by Revenue (2016-2021)
3.3 Global Low Molecular Weight Heparin Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Low Molecular Weight Heparin as of 2020)
3.4 Global Low Molecular Weight Heparin Average Price by Company (2016-2021)
3.5 Manufacturers Low Molecular Weight Heparin Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Low Molecular Weight Heparin Market Size by Type
4.1 Global Low Molecular Weight Heparin Historic Market Review by Type (2016-2021)
4.1.1 Global Low Molecular Weight Heparin Sales Market Share by Type (2016-2021)
4.1.2 Global Low Molecular Weight Heparin Revenue Market Share by Type (2016-2021)
4.1.3 Global Low Molecular Weight Heparin Price by Type (2016-2021)
4.2 Global Low Molecular Weight Heparin Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Low Molecular Weight Heparin Sales Forecast by Type (2022-2027)
4.2.2 Global Low Molecular Weight Heparin Revenue Forecast by Type (2022-2027)
4.2.3 Global Low Molecular Weight Heparin Price Forecast by Type (2022-2027)
5 Global Low Molecular Weight Heparin Market Size by Application
5.1 Global Low Molecular Weight Heparin Historic Market Review by Application (2016-2021)
5.1.1 Global Low Molecular Weight Heparin Sales Market Share by Application (2016-2021)
5.1.2 Global Low Molecular Weight Heparin Revenue Market Share by Application (2016-2021)
5.1.3 Global Low Molecular Weight Heparin Price by Application (2016-2021)
5.2 Global Low Molecular Weight Heparin Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Low Molecular Weight Heparin Sales Forecast by Application (2022-2027)
5.2.2 Global Low Molecular Weight Heparin Revenue Forecast by Application (2022-2027)
5.2.3 Global Low Molecular Weight Heparin Price Forecast by Application (2022-2027)
6 North America Low Molecular Weight Heparin Market Facts & Figures
6.1 North America Low Molecular Weight Heparin Sales by Company
6.1.1 North America Low Molecular Weight Heparin Sales by Company (2016-2021)
6.1.2 North America Low Molecular Weight Heparin Revenue by Company (2016-2021)
6.2 North America Low Molecular Weight Heparin Sales Breakdown by Type
6.2.1 North America Low Molecular Weight Heparin Sales Breakdown by Type (2016-2021)
6.2.2 North America Low Molecular Weight Heparin Sales Breakdown by Type (2022-2027)
6.3 North America Low Molecular Weight Heparin Sales Breakdown by Application
6.3.1 North America Low Molecular Weight Heparin Sales Breakdown by Application (2016-2021)
6.3.2 North America Low Molecular Weight Heparin Sales Breakdown by Application (2022-2027)
7 Europe Low Molecular Weight Heparin Market Facts & Figures
7.1 Europe Low Molecular Weight Heparin Sales by Company
7.1.1 Europe Low Molecular Weight Heparin Sales by Company (2016-2021)
7.1.2 Europe Low Molecular Weight Heparin Revenue by Company (2016-2021)
7.2 Europe Low Molecular Weight Heparin Sales Breakdown by Type
7.2.1 Europe Low Molecular Weight Heparin Sales Breakdown by Type (2016-2021)
7.2.2 Europe Low Molecular Weight Heparin Sales Breakdown by Type (2022-2027)
7.3 Europe Low Molecular Weight Heparin Sales Breakdown by Application
7.3.1 Europe 134 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 134 Sales Breakdown by Application (2022-2027)
8 China Low Molecular Weight Heparin Market Facts & Figures
8.1 China Low Molecular Weight Heparin Sales by Company
8.1.1 China Low Molecular Weight Heparin Sales by Company (2016-2021)
8.1.2 China Low Molecular Weight Heparin Revenue by Company (2016-2021)
8.2 China Low Molecular Weight Heparin Sales Breakdown by Type
8.2.1 China Low Molecular Weight Heparin Sales Breakdown by Type (2016-2021)
8.2.2 China Low Molecular Weight Heparin Sales Breakdown by Type (2022-2027)
8.3 China Low Molecular Weight Heparin Sales Breakdown by Application
8.3.1 China 246 Sales Breakdown by Application (2016-2021)
8.3.2 China 246 Sales Breakdown by Application (2022-2027)
9 Japan Low Molecular Weight Heparin Market Facts & Figures
9.1 Japan Low Molecular Weight Heparin Sales by Company
9.1.1 Japan Low Molecular Weight Heparin Sales by Company (2016-2021)
9.1.2 Japan Low Molecular Weight Heparin Revenue by Company (2016-2021)
9.2 Japan Low Molecular Weight Heparin Sales Breakdown by Type
9.2.1 Japan Low Molecular Weight Heparin Sales Breakdown by Type (2016-2021)
9.2.2 Japan Low Molecular Weight Heparin Sales Breakdown by Type (2022-2027)
9.3 Japan Low Molecular Weight Heparin Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Low Molecular Weight Heparin Market Facts & Figures
10.1 Southeast Asia Low Molecular Weight Heparin Sales by Company
10.1.1 Southeast Asia Low Molecular Weight Heparin Sales by Company (2016-2021)
10.1.2 Southeast Asia Low Molecular Weight Heparin Revenue by Company (2016-2021)
10.2 Southeast Asia Low Molecular Weight Heparin Sales Breakdown by Type
10.2.1 Southeast Asia Low Molecular Weight Heparin Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Low Molecular Weight Heparin Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Low Molecular Weight Heparin Sales Breakdown by Application
10.3.1 Southeast Asia MT Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia MT Sales Breakdown by Application (2022-2027)
11 India Low Molecular Weight Heparin Market Facts & Figures
11.1 India Low Molecular Weight Heparin Sales by Company
11.1.1 India Low Molecular Weight Heparin Sales by Company (2016-2021)
11.1.2 India Low Molecular Weight Heparin Revenue by Company (2016-2021)
11.2 India Low Molecular Weight Heparin Sales Breakdown by Type
11.2.1 India Low Molecular Weight Heparin Sales Breakdown by Type (2016-2021)
11.2.2 India Low Molecular Weight Heparin Sales Breakdown by Type (2022-2027)
11.3 India Low Molecular Weight Heparin Sales Breakdown by Application
11.3.1 India Low Molecular Weight Heparin Sales Breakdown by Application (2016-2021)
11.3.2 India Low Molecular Weight Heparin Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Low Molecular Weight Heparin Business
12.1 Aspen
12.1.1 Aspen Corporation Information
12.1.2 Aspen Business Overview
12.1.3 Aspen Low Molecular Weight Heparin Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Aspen Low Molecular Weight Heparin Products Offered
12.1.5 Aspen Recent Development
12.2 Sanofi-aventis
12.2.1 Sanofi-aventis Corporation Information
12.2.2 Sanofi-aventis Business Overview
12.2.3 Sanofi-aventis Low Molecular Weight Heparin Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Sanofi-aventis Low Molecular Weight Heparin Products Offered
12.2.5 Sanofi-aventis Recent Development
12.3 Pfizer
12.3.1 Pfizer Corporation Information
12.3.2 Pfizer Business Overview
12.3.3 Pfizer Low Molecular Weight Heparin Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Pfizer Low Molecular Weight Heparin Products Offered
12.3.5 Pfizer Recent Development
12.4 Opocrin
12.4.1 Opocrin Corporation Information
12.4.2 Opocrin Business Overview
12.4.3 Opocrin Low Molecular Weight Heparin Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Opocrin Low Molecular Weight Heparin Products Offered
12.4.5 Opocrin Recent Development
12.5 CSBIO
12.5.1 CSBIO Corporation Information
12.5.2 CSBIO Business Overview
12.5.3 CSBIO Low Molecular Weight Heparin Sales, Revenue and Gross Margin (2016-2021)
12.5.4 CSBIO Low Molecular Weight Heparin Products Offered
12.5.5 CSBIO Recent Development
12.6 Dongying Tiandong Pharmaceutical
12.6.1 Dongying Tiandong Pharmaceutical Corporation Information
12.6.2 Dongying Tiandong Pharmaceutical Business Overview
12.6.3 Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin Products Offered
12.6.5 Dongying Tiandong Pharmaceutical Recent Development
12.7 Changzhou Qianhong Bio-pharma
12.7.1 Changzhou Qianhong Bio-pharma Corporation Information
12.7.2 Changzhou Qianhong Bio-pharma Business Overview
12.7.3 Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Products Offered
12.7.5 Changzhou Qianhong Bio-pharma Recent Development
12.8 Techdow
12.8.1 Techdow Corporation Information
12.8.2 Techdow Business Overview
12.8.3 Techdow Low Molecular Weight Heparin Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Techdow Low Molecular Weight Heparin Products Offered
12.8.5 Techdow Recent Development
12.9 Yantai Dongcheng Pharmaceutical Group
12.9.1 Yantai Dongcheng Pharmaceutical Group Corporation Information
12.9.2 Yantai Dongcheng Pharmaceutical Group Business Overview
12.9.3 Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Products Offered
12.9.5 Yantai Dongcheng Pharmaceutical Group Recent Development
13 Low Molecular Weight Heparin Manufacturing Cost Analysis
13.1 Low Molecular Weight Heparin Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Low Molecular Weight Heparin
13.4 Low Molecular Weight Heparin Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Low Molecular Weight Heparin Distributors List
14.3 Low Molecular Weight Heparin Customers
15 Market Dynamics
15.1 Low Molecular Weight Heparin Market Trends
15.2 Low Molecular Weight Heparin Drivers
15.3 Low Molecular Weight Heparin Market Challenges
15.4 Low Molecular Weight Heparin Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Low Molecular Weight Heparin Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Low Molecular Weight Heparin Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Low Molecular Weight Heparin Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Low Molecular Weight Heparin Sales (MT) by Region (2016-2021)
Table 5. Global Low Molecular Weight Heparin Sales Market Share by Region (2016-2021)
Table 6. Global Low Molecular Weight Heparin Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Low Molecular Weight Heparin Revenue Share by Region (2016-2021)
Table 8. Global Low Molecular Weight Heparin Sales (MT) Forecast by Region (2022-2027)
Table 9. Global Low Molecular Weight Heparin Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Low Molecular Weight Heparin Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Low Molecular Weight Heparin Revenue Share Forecast by Region (2022-2027)
Table 12. Global Low Molecular Weight Heparin Sales (MT) of Key Companies (2016-2021)
Table 13. Global Low Molecular Weight Heparin Sales Share by Company (2016-2021)
Table 14. Global Low Molecular Weight Heparin Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Low Molecular Weight Heparin Revenue Share by Company (2016-2021)
Table 16. Global Low Molecular Weight Heparin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Low Molecular Weight Heparin as of 2020)
Table 17. Global Low Molecular Weight Heparin Average Price (USD/MT) of Key Company (2016-2021)
Table 18. Manufacturers Low Molecular Weight Heparin Manufacturing Sites and Area Served
Table 19. Manufacturers Low Molecular Weight Heparin Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Low Molecular Weight Heparin Sales (MT) by Type (2016-2021)
Table 22. Global Low Molecular Weight Heparin Sales Share by Type (2016-2021)
Table 23. Global Low Molecular Weight Heparin Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Low Molecular Weight Heparin Price (USD/MT) by Type (2016-2021)
Table 25. Global Low Molecular Weight Heparin Sales Share by Type (2022-2027)
Table 26. Global Low Molecular Weight Heparin Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Low Molecular Weight Heparin Revenue Share by Type (2022-2027)
Table 28. Global Low Molecular Weight Heparin Price (USD/MT) by Type (2022-2027)
Table 29. Global Low Molecular Weight Heparin Sales (MT) by Application (2016-2021)
Table 30. Global Low Molecular Weight Heparin Sales Share by Application (2016-2021)
Table 31. Global Low Molecular Weight Heparin Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Low Molecular Weight Heparin Price (USD/MT) by Application (2016-2021)
Table 33. Global Low Molecular Weight Heparin Sales (MT) by Application (2022-2027)
Table 34. Global Low Molecular Weight Heparin Sales Share by Application (2022-2027)
Table 35. Global Low Molecular Weight Heparin Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Low Molecular Weight Heparin Revenue Share by Application (2022-2027)
Table 37. Global Low Molecular Weight Heparin Price (USD/MT) by Application (2022-2027)
Table 38. North America Low Molecular Weight Heparin Sales (MT) by Company (2016-2021)
Table 39. North America Low Molecular Weight Heparin Sales Market Share by Company (2016-2021)
Table 40. North America Low Molecular Weight Heparin Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Low Molecular Weight Heparin Revenue Market Share by Company (2016-2021)
Table 42. North America Low Molecular Weight Heparin Sales by Type (2016-2021) & (MT)
Table 43. North America Low Molecular Weight Heparin Sales Market Share by Type (2016-2021)
Table 44. North America Low Molecular Weight Heparin Sales by Type (2022-2027) & (MT)
Table 45. North America Low Molecular Weight Heparin Sales Market Share by Type (2022-2027)
Table 46. North America Low Molecular Weight Heparin Sales by Application (2016-2021) & (MT)
Table 47. North America Low Molecular Weight Heparin Sales Market Share by Application (2016-2021)
Table 48. North America Low Molecular Weight Heparin Sales by Application (2022-2027) & (MT)
Table 49. North America Low Molecular Weight Heparin Sales Market Share by Application (2022-2027)
Table 50. Europe Low Molecular Weight Heparin Sales (MT) by Company (2016-2021)
Table 51. Europe Low Molecular Weight Heparin Sales Market Share by Company (2016-2021)
Table 52. Europe Low Molecular Weight Heparin Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Low Molecular Weight Heparin Revenue Market Share by Company (2016-2021)
Table 54. Europe Low Molecular Weight Heparin Sales by Type (2016-2021) & (MT)
Table 55. Europe Low Molecular Weight Heparin Sales Market Share by Type (2016-2021)
Table 56. Europe Low Molecular Weight Heparin Sales by Type (2022-2027) & (MT)
Table 57. Europe Low Molecular Weight Heparin Sales Market Share by Type (2022-2027)
Table 58. Europe Low Molecular Weight Heparin Sales by Application (2016-2021) & (MT)
Table 59. Europe Low Molecular Weight Heparin Sales Market Share by Application (2016-2021)
Table 60. Europe Low Molecular Weight Heparin Sales by Application (2022-2027) & (MT)
Table 61. Europe Low Molecular Weight Heparin Sales Market Share by Application (2022-2027)
Table 62. China Low Molecular Weight Heparin Sales (MT) by Company (2016-2021)
Table 63. China Low Molecular Weight Heparin Sales Market Share by Company (2016-2021)
Table 64. China Low Molecular Weight Heparin Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Low Molecular Weight Heparin Revenue Market Share by Company (2016-2021)
Table 66. China Low Molecular Weight Heparin Sales by Type (2016-2021) & (MT)
Table 67. China Low Molecular Weight Heparin Sales Market Share by Type (2016-2021)
Table 68. China Low Molecular Weight Heparin Sales by Type (2022-2027) & (MT)
Table 69. China Low Molecular Weight Heparin Sales Market Share by Type (2022-2027)
Table 70. China Low Molecular Weight Heparin Sales by Application (2016-2021) & (MT)
Table 71. China Low Molecular Weight Heparin Sales Market Share by Application (2016-2021)
Table 72. China Low Molecular Weight Heparin Sales by Application (2022-2027) & (MT)
Table 73. China Low Molecular Weight Heparin Sales Market Share by Application (2022-2027)
Table 74. Japan Low Molecular Weight Heparin Sales (MT) by Company (2016-2021)
Table 75. Japan Low Molecular Weight Heparin Sales Market Share by Company (2016-2021)
Table 76. Japan Low Molecular Weight Heparin Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Low Molecular Weight Heparin Revenue Market Share by Company (2016-2021)
Table 78. Japan Low Molecular Weight Heparin Sales by Type (2016-2021) & (MT)
Table 79. Japan Low Molecular Weight Heparin Sales Market Share by Type (2016-2021)
Table 80. Japan Low Molecular Weight Heparin Sales by Type (2022-2027) & (MT)
Table 81. Japan Low Molecular Weight Heparin Sales Market Share by Type (2022-2027)
Table 82. Japan Low Molecular Weight Heparin Sales by Application (2016-2021) & (MT)
Table 83. Japan Low Molecular Weight Heparin Sales Market Share by Application (2016-2021)
Table 84. Japan Low Molecular Weight Heparin Sales by Application (2022-2027) & (MT)
Table 85. Japan Low Molecular Weight Heparin Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Low Molecular Weight Heparin Sales (MT) by Company (2016-2021)
Table 87. Southeast Asia Low Molecular Weight Heparin Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Low Molecular Weight Heparin Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Low Molecular Weight Heparin Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Low Molecular Weight Heparin Sales by Type (2016-2021) & (MT)
Table 91. Southeast Asia Low Molecular Weight Heparin Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Low Molecular Weight Heparin Sales by Type (2022-2027) & (MT)
Table 93. Southeast Asia Low Molecular Weight Heparin Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Low Molecular Weight Heparin Sales by Application (2016-2021) & (MT)
Table 95. Southeast Asia Low Molecular Weight Heparin Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Low Molecular Weight Heparin Sales by Application (2022-2027) & (MT)
Table 97. Southeast Asia Low Molecular Weight Heparin Sales Market Share by Application (2022-2027)
Table 98. India Low Molecular Weight Heparin Sales (MT) by Company (2016-2021)
Table 99. India Low Molecular Weight Heparin Sales Market Share by Company (2016-2021)
Table 100. India Low Molecular Weight Heparin Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Low Molecular Weight Heparin Revenue Market Share by Company (2016-2021)
Table 102. India Low Molecular Weight Heparin Sales by Type (2016-2021) & (MT)
Table 103. India Low Molecular Weight Heparin Sales Market Share by Type (2016-2021)
Table 104. India Low Molecular Weight Heparin Sales by Type (2022-2027) & (MT)
Table 105. India Low Molecular Weight Heparin Sales Market Share by Type (2022-2027)
Table 106. India Low Molecular Weight Heparin Sales by Application (2016-2021) & (MT)
Table 107. India Low Molecular Weight Heparin Sales Market Share by Application (2016-2021)
Table 108. India Low Molecular Weight Heparin Sales by Application (2022-2027) & (MT)
Table 109. India Low Molecular Weight Heparin Sales Market Share by Application (2022-2027)
Table 110. Aspen Corporation Information
Table 111. Aspen Description and Business Overview
Table 112. Aspen Low Molecular Weight Heparin Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 113. Aspen Low Molecular Weight Heparin Product
Table 114. Aspen Recent Development
Table 115. Sanofi-aventis Corporation Information
Table 116. Sanofi-aventis Description and Business Overview
Table 117. Sanofi-aventis Low Molecular Weight Heparin Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 118. Sanofi-aventis Low Molecular Weight Heparin Product
Table 119. Sanofi-aventis Recent Development
Table 120. Pfizer Corporation Information
Table 121. Pfizer Description and Business Overview
Table 122. Pfizer Low Molecular Weight Heparin Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 123. Pfizer Low Molecular Weight Heparin Product
Table 124. Pfizer Recent Development
Table 125. Opocrin Corporation Information
Table 126. Opocrin Description and Business Overview
Table 127. Opocrin Low Molecular Weight Heparin Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 128. Opocrin Low Molecular Weight Heparin Product
Table 129. Opocrin Recent Development
Table 130. CSBIO Corporation Information
Table 131. CSBIO Description and Business Overview
Table 132. CSBIO Low Molecular Weight Heparin Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 133. CSBIO Low Molecular Weight Heparin Product
Table 134. CSBIO Recent Development
Table 135. Dongying Tiandong Pharmaceutical Corporation Information
Table 136. Dongying Tiandong Pharmaceutical Description and Business Overview
Table 137. Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 138. Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin Product
Table 139. Dongying Tiandong Pharmaceutical Recent Development
Table 140. Changzhou Qianhong Bio-pharma Corporation Information
Table 141. Changzhou Qianhong Bio-pharma Description and Business Overview
Table 142. Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 143. Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Product
Table 144. Changzhou Qianhong Bio-pharma Recent Development
Table 145. Techdow Corporation Information
Table 146. Techdow Low Molecular Weight Heparin Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 147. Techdow Description and Business Overview
Table 148. Techdow Low Molecular Weight Heparin Product
Table 149. Techdow Recent Development
Table 150. Yantai Dongcheng Pharmaceutical Group Corporation Information
Table 151. Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 152. Yantai Dongcheng Pharmaceutical Group Description and Business Overview
Table 153. Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Product
Table 154. Yantai Dongcheng Pharmaceutical Group Recent Development
Table 155. Production Base and Market Concentration Rate of Raw Material
Table 156. Key Suppliers of Raw Materials
Table 157. Low Molecular Weight Heparin Distributors List
Table 158. Low Molecular Weight Heparin Customers List
Table 159. Low Molecular Weight Heparin Market Trends
Table 160. Low Molecular Weight Heparin Market Drivers
Table 161. Low Molecular Weight Heparin Market Challenges
Table 162. Low Molecular Weight Heparin Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Low Molecular Weight Heparin Product Picture
Figure 2. Global Low Molecular Weight Heparin Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Low Molecular Weight Heparin Sales Market Share by Application in 2021 & 2027
Figure 6. Treatment of Venous Thromboembolism Examples
Figure 7. Complications of Pregnancy Examples
Figure 8. Cardioversion of Atrial Fibrillation/Flutter Examples
Figure 9. Others Examples
Figure 10. Global Low Molecular Weight Heparin Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Low Molecular Weight Heparin Sales Growth Rate (2016-2027) & (US$ Million)
Figure 12. Global Low Molecular Weight Heparin Sales (MT) Growth Rate (2016-2027)
Figure 13. Global Low Molecular Weight Heparin Price Trends Growth Rate (2016-2027) (USD/MT)
Figure 14. Global Low Molecular Weight Heparin Revenue Market Share by Region: 2016 VS 2021
Figure 15. Global Low Molecular Weight Heparin Revenue Market Share by Region: 2021 VS 2027
Figure 16. North America Low Molecular Weight Heparin Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. North America Low Molecular Weight Heparin Sales (MT) Growth Rate (2016-2027)
Figure 18. Europe Low Molecular Weight Heparin Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. Europe Low Molecular Weight Heparin Sales (Million USD) Growth Rate (2016-2027)
Figure 20. China Low Molecular Weight Heparin Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. China Low Molecular Weight Heparin Sales (Million USD) and Growth Rate (2016-2027)
Figure 22. Japan Low Molecular Weight Heparin Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Japan Low Molecular Weight Heparin Sales (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Low Molecular Weight Heparin Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. Southeast Asia Low Molecular Weight Heparin Sales (Million USD) Growth Rate (2016-2027)
Figure 26. India Low Molecular Weight Heparin Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. India Low Molecular Weight Heparin Sales (Million USD) Growth Rate (2016-2027)
Figure 28. Global 5 Largest Low Molecular Weight Heparin Players Market Share by Revenue in Low Molecular Weight Heparin: 2016 & 2020
Figure 29. Low Molecular Weight Heparin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 30. Global Low Molecular Weight Heparin Revenue Share by Type (2016-2021)
Figure 31. Global Low Molecular Weight Heparin Revenue Growth Rate by Type in 2016 & 2020
Figure 32. Global Low Molecular Weight Heparin Revenue Share by Application (2016-2021)
Figure 33. Global Low Molecular Weight Heparin Revenue Growth Rate by Application in 2016 & 2020
Figure 34. North America Low Molecular Weight Heparin Sales Market Share by Type in 2020
Figure 35. North America Low Molecular Weight Heparin Sales Market Share by Application in 2020
Figure 36. Europe Low Molecular Weight Heparin Sales Market Share by Type in 2020
Figure 37. Europe Low Molecular Weight Heparin Sales Market Share by Application in 2020
Figure 38. China Low Molecular Weight Heparin Sales Market Share by Type in 2020
Figure 39. China Low Molecular Weight Heparin Sales Market Share by Application in 2020
Figure 40. Japan Low Molecular Weight Heparin Sales Market Share by Type in 2020
Figure 41. Japan Low Molecular Weight Heparin Sales Market Share by Application in 2020
Figure 42. Southeast Asia Low Molecular Weight Heparin Sales Market Share by Type in 2020
Figure 43. Southeast Asia Low Molecular Weight Heparin Sales Market Share by Application in 2020
Figure 44. India Low Molecular Weight Heparin Sales Market Share by Type in 2020
Figure 45. India Low Molecular Weight Heparin Sales Market Share by Application in 2020
Figure 46. Key Raw Materials Price Trend
Figure 47. Manufacturing Cost Structure of Low Molecular Weight Heparin
Figure 48. Manufacturing Process Analysis of Low Molecular Weight Heparin
Figure 49. Low Molecular Weight Heparin Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
ヘパリン（低分子量）のグローバル市場調査 2019年 The global Heparin (Low Molecular Weight) market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Heparin (Low Molecular Weight) volume and value at global level, regional level and company level. From a gl…- 低分子量ヘパリン（LMWH）のグローバル市場調査 2019年 The global Low Molecular Weight Heparin (LMWHs) market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Low Molecular Weight Heparin (LMWHs) volume and value at global level, regional level and company leve…
- 低分子量ヘパリンナトリウムのグローバル市場調査 2019年 The global Low Molecular Weight Heparin Sodium market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Low Molecular Weight Heparin Sodium volume and value at global level, regional level and company level.…
- 超低分子量ヘパリン(ULMWH) のグローバル市場調査 2019年 The global Ultra-low Molecular Weight Heparin (ULMWH) market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Ultra-low Molecular Weight Heparin (ULMWH) volume and value at global level, regional level and …
- 超低分子量ヘパリン(ULMWH) のグローバル市場調査 2019年 The global Ultra-low Molecular Weight Heparin (ULMWH) market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Ultra-low Molecular Weight Heparin (ULMWH) volume and value at global level, regional level and …